EKSO (Ekso Bionics Holdings) Cyclically Adjusted FCF per Share: $-87.30 (As of Mar. 2026)


EKSO Ekso Bionics Holdings Inc EKSO
32 GF Score
Price $11.65
GF Value $4.40
! 10 Warning Signs
View Full Analysis

What is Ekso Bionics Holdings Cyclically Adjusted FCF per Share?

Ekso Bionics Holdings EKSO -0.42% 32 Cyclically Adjusted FCF per Share is $-87.30 as of Mar. 2026. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.40. The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ekso Bionics Holdings's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.596. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-87.30 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Ekso Bionics Holdings was 13.80% per year. The lowest was 4.60% per year. And the median was 9.20% per year.

As of today (2026-07-13), Ekso Bionics Holdings's current stock price is $11.65. Ekso Bionics Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-87.30. Ekso Bionics Holdings's Cyclically Adjusted Price-to-FCF of today is .


Ekso Bionics Holdings  (NAS:EKSO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ekso Bionics Holdings Cyclically Adjusted FCF per Share Related Terms


Ekso Bionics Holdings Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Ekso Bionics Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekso Bionics Holdings Cyclically Adjusted FCF per Share Chart

Ekso Bionics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -143.51 -150.51 -152.79 -124.41 -96.43

Ekso Bionics Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -119.55 -112.84 -105.54 -96.43 -87.30

EKSO vs POCI, HBIO, NEPH: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Cyclically Adjusted Price-to-FCF falls into.


EKSO
32GF Score
Ekso Bionics Holdings Inc EKSO
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ekso Bionics Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ekso Bionics Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.596/330.2130*330.2130
=-0.596

Current CPI (Mar. 2026) = 330.2130.

Ekso Bionics Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -81.330 241.018 -111.428
201609 -78.143 241.428 -106.880
201612 -49.588 241.432 -67.823
201703 -76.206 243.801 -103.216
201706 -85.973 244.955 -115.896
201709 -57.325 246.819 -76.694
201712 -21.605 246.524 -28.939
201803 -25.378 249.554 -33.580
201806 -22.524 251.989 -29.516
201809 -15.484 252.439 -20.254
201812 -18.760 251.233 -24.658
201903 -17.938 254.202 -23.302
201906 -14.599 256.143 -18.821
201909 -13.721 256.759 -17.646
201912 -4.371 256.974 -5.617
202003 -4.450 258.115 -5.693
202006 -9.647 257.797 -12.357
202009 -2.272 260.280 -2.882
202012 -3.129 260.474 -3.967
202103 -2.789 264.877 -3.477
202106 -4.247 271.696 -5.162
202109 -2.922 274.310 -3.517
202112 -3.635 278.802 -4.305
202203 -4.954 287.504 -5.690
202206 -4.945 296.311 -5.511
202209 -2.974 296.808 -3.309
202212 -4.155 296.797 -4.623
202303 -4.804 301.836 -5.256
202306 -3.254 305.109 -3.522
202309 -3.593 307.789 -3.855
202312 -1.690 306.746 -1.819
202403 -2.992 312.332 -3.163
202406 -2.198 314.175 -2.310
202409 -1.688 315.301 -1.768
202412 -0.884 315.605 -0.925
202503 -1.167 319.799 -1.205
202506 -1.598 322.561 -1.636
202509 -0.792 324.800 -0.805
202512 -1.390 324.054 -1.416
202603 -0.596 330.213 -0.596

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-87.30 mean?
Ekso Bionics Holdings (EKSO) has a Cyclically Adjusted FCF per Share of $-87.30 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ekso Bionics Holdings and its competitors.
Is Ekso Bionics Holdings' Cyclically Adjusted FCF per Share too high?
Ekso Bionics Holdings' current Cyclically Adjusted FCF per Share is $-87.30. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' Cyclically Adjusted FCF per Share compare to POCI and HBIO?
Ekso Bionics Holdings' Cyclically Adjusted FCF per Share of $-87.30 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ekso Bionics Holdings and its competitors. Ekso Bionics Holdings's current Cyclically Adjusted FCF per Share is $-87.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Ekso Bionics Holdings (EKSO) has a current Cyclically Adjusted FCF per Share of $-87.30. The stock's GF Value™ is $4.40, compared to a current price of $11.65 — trading 164.8% above its estimated fair value. The current Cyclically Adjusted FCF per Share is $-87.30. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current Cyclically Adjusted FCF per Share is $-87.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?

Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued. The current stock price of $11.65 is trading 164.8% above its estimated GF Value™ of $4.40.

Key valuation signals for EKSO:

  • Cyclically Adjusted FCF per Share: $-87.30
  • GF Value™: $4.40 vs. price of $11.65 (164.8% above fair value)
  • GF Score™: 32/100 with 10 warning signs

No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ekso Bionics Holdings Business Description

Address 101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score

Get the complete analysis for EKSO

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.65
Price
$4.40
GF Value